Good news: Irinotecan hydrochloride has once again passed the official audit of Japan's PMDA

2016-04-01

On April 12-14, 2016, Japan's PMDA conducted a 3-day audit of Sichuan Xieli's product Irinotecan Hydrochloride, and the audit results confirmed that Xieli's product met the official Japanese GMP requirements.

2026-10-17

Concluded with Distinction in Milan • Successfully Passed E...

2026-09-22

Craftsmanship of Xieli, New‑start in the Greater Bay Area |...

2026-08-28

Ingenuity in Plant‑derived Extracts, Powering Global Expans...

2026-07-09

Good News | Sichuan Xieli Pharmaceutical Awarded EcoVadis Br...

2026-06-17

New CEP Certificate Granted – Ursodeoxycholic Acid Hits New...